WUHAN RENFU BIOMEDICAL INDUSTRY INVESTMENT FUND CENTER
Wuhan Renfu Biomedical Industry Investment Fund Center is an investment firm.
WUHAN RENFU BIOMEDICAL INDUSTRY INVESTMENT FUND CENTER
Industry:
Finance Financial Services
Status:
Active
Similar Organizations
Bank of China Group Investment
Bank of China Group Investment is an investment firm.
Hefei High Tech Industry Investment
Hefei High Tech Industry Investment is an investment firm.
Shanghai Guangya Investment
Shanghai Guangya Investment is an investment firm.
Wuhan Optics Valley Industrial Investment
Wuhan Optics Valley Industrial Investment is an investment firm.
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2019-03-11 | Yaohai Bio | Wuhan Renfu Biomedical Industry Investment Fund Center investment in Series A - Yaohai Bio | 50 M CNY |
More informations about "Wuhan Renfu Biomedical Industry Investment Fund Center"
Wuhan Renfu Biological Medicine Industryinvestment Fund Center …
Find company research, competitor information, contact details & financial data for Wuhan Renfu Biological Medicine Industryinvestment Fund Center (Limited Partners hip) of Wuhan, Hubei. …See details»
Wuhan Renfu Biomedical Industry Investment Fund Center
Mar 11, 2019 Wuhan Renfu Biomedical Industry Investment Fund Center is an investment firm. ... Wuhan Renfu Biomedical Industry Investment Fund Center has invested in Yaohai ...See details»
Wuhan Renfu Biomedical Industry Investment Fund Center
Wuhan Renfu Biomedical Industry Investment Fund Center is an investment firm.See details»
Spotlight on Wuhan - PMC - PubMed Central (PMC)
Heavy investment in science and technology research means Wuhan is becoming a competitive and innovative power in China. WUHAN SITS at the intersection of the Han and Yangtze …See details»
Wuhan Institute of Biological Products - Wikipedia
The Wuhan Institute of Biological Products (WIBP Chinese: 武汉生物制品研究所) or Wuhan Institute of Biology for short is a subsidiary of China National Pharmaceutical Group, a …See details»
Jiangsu Yaohai Bio-pharmaceutical Co.Ltd. Asset Profile - Preqin
Content featuring industry thought leaders. Resources. Free Benchmarks See Preqin Benchmarks in action. ... Wuhan Renfu Biomedical Industry Investment Fund Center, Lotus …See details»
The roadmap of bioeconomy in China - PMC - National Center for ...
Nov 30, 2022 This work was financially supported by grants from the Ministry of Science and Technology of China (Grant No. 2018YFA0900200), National Natural Science Foundation of …See details»
US suspends federal funding to Wuhan lab over non-compliance
Jul 19, 2023 The U.S. has suspended federal funding to China's Wuhan Institute of Virology (WIV) for failing to provide documentation related to concerns over biosafety protocol …See details»
iRegene Asset Profile | Preqin
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, …See details»
NIH official finally admits taxpayers funded gain-of-function
It’s about time! At long last, National Institutes of Health (NIH) principal deputy director Lawrence Tabak admitted to Congress Thursday that US taxpayers funded gain-of-function research at ...See details»
15 Chinese Companies to Watch in April 2022 – Healthcare
May 12, 2022 Biosurf (Chinese: 百赛飞), a functional biological coating developer, raised over CNY 100 million (USD 15.12 million) in a Series B financing round from Huatai Zijin …See details»
Wuhan Guanggu Renfu Biomedical Venture Capital Fund Center …
Find company research, competitor information, contact details & financial data for Wuhan Guanggu Renfu Biomedical Venture Capital Fund Center (Limited Partnership) of Wuhan, …See details»
Biotech in China 2021, at the beginning of the 14th five-year …
The technology trading center CTEX-TT offers technology transfer to industry through 67 local, 17 professional, and 3 international channels c: Academia and industry: 20 state venture capital …See details»
Biotech booms in China - Nature
Jan 17, 2018 ChinaBio reports that Chinese venture capital and private equity funds raised $45 billion over a period of 30 months for life-sciences investment. Money is flowing into academic …See details»
Official Ground-breaking Ceremony of Wuhan Synthetic Biology …
WUHAN, China, Oct. 20, 2022 /PRNewswire/ -- On October 19th, 2022, the investment project of the CABIO R&D Center officially commenced in Wuhan Optical Valley.Upon the basis of the said investment ...See details»
HiComp Microtech(Suzhou)Co.,Ltd Asset Profile | Preqin
Content featuring industry thought leaders. Resources. Free Benchmarks See Preqin Benchmarks in action. ... Wuhan Renfu Biomedical Industry Investment Fund Center, CAS …See details»
Biotech in China 2021, at the beginning of the 14th five-year …
May 3, 2021 Abstract As China assumes a more and more dominant role in global science, this mini-review attempts to provide a bird’s eye view on how the bio-digital revolution impacts …See details»
The influence of "industry policy" and "financial institution ...
Jan 8, 2024 The biomedical industry is characterized by high risk, high investment, high technology and long cycle, and each stage contains risks and challenges. How to optimize the …See details»
Wuhan Guanggurenfuxincheng Biological Medicine Industry …
Find company research, competitor information, contact details & financial data for Wuhan Guanggurenfuxincheng Biological Medicine Industry Investment Fund Center ( Limited …See details»